文献速递心血管US

低危患者经导管与外科主动脉瓣置换术的5年超声心动图结果

5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
PubMed 文献 · JACC Cardiovasc Imaging · 2025-04-16

PARTNER 3试验将1000例低危症状性重度主动脉瓣狭窄患者随机分配至SAPIEN 3经导管主动脉瓣置换术(TAVR)或外科主动脉瓣置换术,5年超声心动图核心实验室分析显示TAVR组≥轻度主动脉瓣反流发生率高于外科组(24.5% vs 6.3%,P < 0.001),但两组瓣膜血流动力学稳定,TAVR组低流速状态更少、瓣膜-动脉阻抗更低、右心室功能更好。

要点

  • TAVR组5年≥轻度主动脉瓣反流发生率高于外科组(24.5% vs 6.3%,P < 0.001),两组≥中度反流均较低。
  • TAVR组平均跨主动脉瓣压差高于外科组(12.8 ± 6.5 vs 11.7 ± 5.6 mm Hg,P < 0.001),但瓣膜面积两组差异无统计学意义(P = 0.895)。
  • 30天时低右心室-肺动脉耦合和高瓣膜-动脉阻抗与5年复合终点风险增加相关。

核心结论

  • 在低危重度主动脉瓣狭窄患者中,与外科主动脉瓣置换术相比,TAVR与5年相似的稳定瓣膜血流动力学相关,且低流速状态更少、瓣膜-动脉阻抗更低、右心室功能更好。

研究设计与样本

  • PARTNER 3试验为随机对照试验,纳入1000例低危症状性重度主动脉瓣狭窄患者,随机分配至SAPIEN 3 TAVR或外科主动脉瓣置换术,超声心动图于基线、30天、1年及每年至5年由核心实验室联盟分析,复合主要终点(死亡、卒中或再住院)由临床事件委员会裁定。

关键影像表现/征象

  • TAVR组5年≥轻度主动脉瓣反流发生率高于外科组(24.5% vs 6.3%,P < 0.001),两组≥中度主动脉瓣反流均较低。
  • TAVR组平均跨主动脉瓣压差高于外科组(12.8 ± 6.5 vs 11.7 ± 5.6 mm Hg,P < 0.001)。
  • TAVR组每搏输出量指数高于外科组(44.6 ± 9.7 vs 41.1 ± 9.2,P < 0.0001)。
  • TAVR组主动脉瓣面积与外科组差异无统计学意义(1.87 ± 0.46 vs 1.82 ± 0.46,P = 0.895)。
  • TAVR组三尖瓣环收缩期位移更高(P < 0.001),右心室-肺动脉耦合也更高(P < 0.0001)。

临床应用与阅片要点

  • TAVR术后5年随访中≥轻度主动脉瓣反流较外科组更常见(24.5% vs 6.3%),阅片时需注意评估反流程度。
  • TAVR组平均跨主动脉瓣压差虽高于外科组(12.8 ± 6.5 vs 11.7 ± 5.6 mm Hg),但两组瓣膜面积无显著差异(P = 0.895)。
  • 30天时低右心室-肺动脉耦合和高瓣膜-动脉阻抗与5年复合主要终点风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients with Aortic Stenosis) trial compared SAPIEN 3 transcatheter aortic valve replacement (TAVR) to surgery in low-risk patients with symptomatic, severe aortic stenosis. Echocardiographic outcomes at 5 years are unknown.

OBJECTIVES: This study sought to compare 5-year echocardiographic results of TAVR and surgery in the PARTNER 3 trial.

METHODS: Echocardiograms for 1,000 randomized patients were obtained at baseline, 30 days, 1 year, and annually through 5 years and were analyzed by a core lab consortium. The composite primary endpoint of death, stroke, or rehospitalization was adjudicated by a clinical events committee.

RESULTS: At 5 years, ≥ mild aortic regurgitation was higher following TAVR vs surgery (24.5% vs 6.3%; P < 0.001), with low ≥ moderate aortic regurgitation in both groups. TAVR patients had higher mean transaortic gradient (12.8 ± 6.5 vs 11.7 ± 5.6 mm Hg; P < 0.001), stroke volume index (44.6 ± 9.7 vs 41.1 ± 9.2; P < 0.0001), and aortic valve area (1.87 ± 0.46 vs 1.82 ± 0.46; P = 0.895). Fewer TAVR patients had low-flow stroke volume index (P < 0.001) and left ventricular hemodynamic burden (valvulo-arterial impedance; P < 0.01). Tricuspid annular plane systolic excursion was also higher with TAVR (P < 0.001), as was right ventricular-to-pulmonary artery coupling (P < 0.0001). In the combined cohorts, 30-day moderate to severe prosthesis-patient mismatch, mild to severe aortic regurgitation, or low stroke volume index were not predictive of clinical outcomes; only low right ventricular-to-pulmonary artery coupling and high valvulo-arterial impedance at 30 days were associated with increased risk of the 5-year composite primary endpoint.

CONCLUSIONS: In low-risk patients with severe aortic stenosis, TAVR, compared to surgery, was associated with similar, stable valve hemodynamics at 5 years with less frequent low-flow state, lower valvulo-arterial impedance, and better right ventricular function. (PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients with Aortic Stenosis [P3]; NCT02675114).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hahn RT, Ternacle J, Silva I, et al. 5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. JACC Cardiovasc Imaging. 2025. PMID: 40243974. doi:10.1016/j.jcmg.2025.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。